← Compound index
RESEARCH FAMILY / SEDATIN-ANALOGUES

Sedatin & dermorphin analoguesСедатин / аналоги дерморфина

A family of synthetic dermorphin-related peptides studied in tissue homeostasis, oxidative injury and opioid pharmacology.

StressRecovery
Source linked

What the studies found

Lab research · 2016

Cytoprotective Effect of Peptide Sedatin, an Agonist of μ/δ-Opioid Receptors, on Primary Culture of Pulmonary Fibroblasts of Albino Rats under Conditions of Oxidative Stress.

Sedatin preserved selected oxidative-stress and nuclear measures in rat pulmonary fibroblasts. Naloxone partially reduced these effects, supporting opioid involvement in this assay.

Study notes · methods, sources and limitations

Participants or model Primary rat pulmonary fibroblasts

Important limitations

  • Preclinical findings do not establish human benefit or safety. Abstract only. Full methods and independent replication remain unconfirmed.

Bulletin of experimental biology and medicine · Indexed abstract

Original source or citation ↗

Study results and tables ↗

Animal research · 2009

Protective effect of dermorphin analogue sedatin on indomethacin-induced injury to the gastric mucosa.

Ulcer/erosion area and oxidative stress
Reductions reportedNo numerical injury-area changes supplied
Non-arginine analogue
No DNA-synthesis stimulation or oxidative-stress effect
L-NAME pretreatment
Blocked Sedatin-related DNA-synthesis modulation

Sedatin pretreatment reduced indomethacin-induced gastric injury in mice; the Arg-free comparator did not reproduce the same pattern.

Study notes · methods, sources and limitations

Participants or model Mice; experimental gastric injury

Design Mouse gastric-injury model: indomethacin 250 mg/kg; five pretreatments with Sedatin 100 micrograms/kg.

Important limitations

  • Preclinical findings do not establish human benefit or safety. Abstract only. Full methods and independent replication remain unconfirmed.
  • Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Bulletin of experimental biology and medicine · Indexed abstract

Original source or citation ↗

Study results and tables ↗

Animal research · 2007

Effect of synthetic dermorphin analogues on tissue homeostasis in the myocardium of newborn albino rats.

Sedatin changed myocardial DNA-synthesis, nucleolar and oxidative measures in newborn rats. Its Arg-free analogue showed little effect in this experiment.

Study notes · methods, sources and limitations

Participants or model Newborn rats; myocardial tissue assays

Important limitations

  • Preclinical findings do not establish human benefit or safety. Abstract only. Full methods and independent replication remain unconfirmed.

Bulletin of experimental biology and medicine · Indexed abstract

Original source or citation ↗

Study results and tables ↗
01 / OVERVIEW

About Sedatin & dermorphin analogues

Names in this research collection

Sedatin · A10 · A17 · A43 · Dermorphin · Arg-free Sedatin · RU2067000

Compound class
Peptide research family
Research collection
Opioid-peptide cytoprotection · editorial grouping
Institutions in linked studies
See individual study records
Source review
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH

Understanding the evidence

Human research

No human treatment trial assessed for this family

Study methods

Member-specific studies; patents and archival leads identified separately

Independent replication

Independent replication not established by the records collected here

Source access

Primary abstracts, selected full texts, patents and explicit retrieval targets

Safety evidence

Cell and animal effects do not establish human safety; analogues may differ

Open a topic for the evidence assessment.

More findings, background and history
IDENTITY / MEMBER-SPECIFIC EVIDENCE

Inside this research family

Grouping supports navigation. It does not imply equivalent composition, mechanisms, effectiveness or safety.

Research objects, findings and source boundaries
MemberIdentityWhat the source supports
SedatinArg–Tyr–D-Ala–Phe–Gly

Patent-defined peptide with cell and animal tissue-injury research.

Peptide, preparation and pharmaceutical composition — US6248716B1 ↗

Cytoprotective Effect of Peptide Sedatin, an Agonist of μ/δ-Opioid Receptors, on Primary Culture of Pulmonary Fibroblasts of Albino Rats under Conditions of Oxidative Stress. ↗

Protective effect of dermorphin analogue sedatin on indomethacin-induced injury to the gastric mucosa. ↗

Arg-free comparatorTyr–D-Ala–Phe–Gly

Did not reproduce all Sedatin findings in the linked animal experiments.

Effect of synthetic dermorphin analogues on tissue homeostasis in the myocardium of newborn albino rats. ↗

Protective effect of dermorphin analogue sedatin on indomethacin-induced injury to the gastric mucosa. ↗

A10 / A17 / A43Historical laboratory-code series

A10: Tyr–D-Orn–Phe–Gly; A17: Arg–Tyr–D-Lys–Phe–Gly; A43: Arg–Tyr–D-Arg–Phe–D-Ala–NH₂. Transcription checked; original scan pending.

Morphogenetic activity of dermorphin and its analogues in different cell populations ↗

Interpretation and open questions

The broad patent scaffold does not prove that every number between A10 and A43 corresponds to a tested molecule.

Tissue DNA-synthesis and oxidative markers are not demonstrated recovery benefits in people.

Explore the Russian peptide research map ↗

What remains unclear

The original report and protocol would clarify group sizes, background treatment and translation. Independent replication and equivalence to current products remain uncertain.

No human intervention report has been identified among the linked records; unclassified archival leads may remain. Several publications can describe the same participants.

Browse original study records ↗
PATENT RESEARCH / COLLECTION UPDATED 7 NOVEMBER 2026

Patents and claimed inventions

These 1 grouped records distinguish claimed molecules, uses, formulations and related chemistry. Patent disclosure does not establish clinical benefit or approval.

2001 · US6248716B1 · Peptide, preparation and pharmaceutical composition — US6248716B1Use · 233.2 ± 2.4 kg treated versus 189.0 ± 2.7 kg control; 12 animals/group

Reported findings

A preparation tested in the patent was associated with greater weight gain in a small animal-production comparison.

Cattle weight gain
233.2 ± 2.4 kg treated versus 189.0 ± 2.7 kg control; 12 animals/groupStarting weights 72.3 ± 0.9 and 72.2 ± 1.1 kg; not human therapeutic benefit
Daily gain
752 ± 17.3 g/day versus 610 ± 15.8 g/daySame cattle example; observation duration not independently entered
All reported results, comparisons and limitations →

Use. Stress-related method claims involving defined peptide analogues in the sedatin/dermorphin research trail; sequence and terminal modifications limit transfer to other analogues.

A patent disclosure is not clinical proof, marketing approval or a legal opinion. Related publications and patent family members may describe the same experiments.

Publication
US6248716B1 ↗ · 2001-06-19
Earliest priority / filing
1995-06-27 / 1999-05-27
Original applicant / assignee
Immunotech Developments Inc
Indexed status
Expired - Lifetime · checked 2026-11-06
Patent family
27082120 · family publications are related filings, not independent studies.
Original title, inventors and related publications

Peptide, a method for its preparation and a pharmaceutical composition containing the peptide

Inventors: Vladislav I. Deigin; Elena P. Yarova.

US6248716B1

Original patent PDF ↗

Read source review →

Status is an indexed snapshot, not an official legal assessment. Search the patent collection and read the method →

03 / SOURCE RECORDS

Findings by study

Explore related research ↗

Lab research · 2016

Cytoprotective Effect of Peptide Sedatin, an Agonist of μ/δ-Opioid Receptors, on Primary Culture of Pulmonary Fibroblasts of Albino Rats under Conditions of Oxidative Stress.

Sedatin preserved selected oxidative-stress and nuclear measures in rat pulmonary fibroblasts. Naloxone partially reduced these effects, supporting opioid involvement in this assay.

Study notes and original source
2016In vitroEnglish abstract

Cytoprotective Effect of Peptide Sedatin, an Agonist of μ/δ-Opioid Receptors, on Primary Culture of Pulmonary Fibroblasts of Albino Rats under Conditions of Oxidative Stress.

Sazonova EN, Samarina EY, Lebed'ko OA, Maltseva IM, Timoshin SS · Bulletin of experimental biology and medicine

Sedatin preserved selected oxidative-stress and nuclear measures in rat pulmonary fibroblasts. Naloxone partially reduced these effects, supporting opioid involvement in this assay.

Population / setting
Primary rat pulmonary fibroblasts
Source reviewed
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Study limitations
  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Reviewed 2026-10-05.

Read the source ↗

Animal research · 2009

Protective effect of dermorphin analogue sedatin on indomethacin-induced injury to the gastric mucosa.

Sedatin pretreatment reduced indomethacin-induced gastric injury in mice; the Arg-free comparator did not reproduce the same pattern.

Study notes and original source
2009Animal / experimentalEnglish abstract

Protective effect of dermorphin analogue sedatin on indomethacin-induced injury to the gastric mucosa.

Fleishman MY, Zhivotova EY, Lebedko OA, Deigin VI, Timoshin SS · Bulletin of experimental biology and medicine

Sedatin pretreatment reduced indomethacin-induced gastric injury in mice; the Arg-free comparator did not reproduce the same pattern.

Results and tables

Reported findings and study design

Mouse gastric-injury model: indomethacin 250 mg/kg; five pretreatments with Sedatin 100 micrograms/kg.

Population or model Mice; experimental gastric injury

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Ulcer/erosion area and oxidative stressReductions reportedNo numerical injury-area changes supplied
Non-arginine analogueNo DNA-synthesis stimulation or oxidative-stress effect
L-NAME pretreatmentBlocked Sedatin-related DNA-synthesis modulation

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Population / setting
Mice; experimental gastric injury
Source reviewed
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Study limitations
  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Reviewed 2026-10-05.

Read the source ↗

Animal research · 2007

Effect of synthetic dermorphin analogues on tissue homeostasis in the myocardium of newborn albino rats.

Sedatin changed myocardial DNA-synthesis, nucleolar and oxidative measures in newborn rats. Its Arg-free analogue showed little effect in this experiment.

Study notes and original source
2007Animal / experimentalEnglish abstract

Effect of synthetic dermorphin analogues on tissue homeostasis in the myocardium of newborn albino rats.

Kriganovskaya SY, Lebed'ko OA, Sazonova EN, Timoshin SS, Molokanova LE · Bulletin of experimental biology and medicine

Sedatin changed myocardial DNA-synthesis, nucleolar and oxidative measures in newborn rats. Its Arg-free analogue showed little effect in this experiment.

Population / setting
Newborn rats; myocardial tissue assays
Source reviewed
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Study limitations
  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Reviewed 2026-10-05.

Read the source ↗

Experiment described in a patent · 2001

Peptide, preparation and pharmaceutical composition — US6248716B1

The Sedatin patent documents Arg–Tyr–D-Ala–Phe–Gly and related peptide chemistry. Related scaffold claims in RU2067000C1 do not establish that every possible A-number was synthesized or tested.

Cattle weight gain · 233.2 ± 2.4 kg treated versus 189.0 ± 2.7 kg control; 12 animals/group · Starting weights 72.3 ± 0.9 and 72.2 ± 1.1 kg; not human therapeutic benefit

Study notes and original source
2001Patent / reported experimentsFull text available

Peptide, preparation and pharmaceutical composition — US6248716B1

· Primary source linked above

The Sedatin patent documents Arg–Tyr–D-Ala–Phe–Gly and related peptide chemistry. Related scaffold claims in RU2067000C1 do not establish that every possible A-number was synthesized or tested.

Results and tables

Reported patent results

Reported findings

A preparation tested in the patent was associated with greater weight gain in a small animal-production comparison.

Broad peptide-analogue patent with multiple animal experiments; the selected numerical example concerns cattle growth.

Population or model Broad peptide-analogue patent with multiple animal experiments; the selected numerical example concerns cattle growth.

Results · Table 13: cattle growth comparison; broad candidate scope explicitly limited.
MeasureResultComparison, timing and statistics
Cattle weight gain233.2 ± 2.4 kg treated versus 189.0 ± 2.7 kg control; 12 animals/groupStarting weights 72.3 ± 0.9 and 72.2 ± 1.1 kg; not human therapeutic benefit
Daily gain752 ± 17.3 g/day versus 610 ± 15.8 g/daySame cattle example; observation duration not independently entered

The broad patent contains different peptide constructs and experiments. This animal example cannot establish a human anti-stress effect or be assigned to every Sedatin/dermorphin analogue.

Source for these results ↗ · Reviewed 2026-11-06

Population / setting
Broad peptide-analogue patent with multiple animal experiments; the selected numerical example concerns cattle growth.
Source reviewed
Selected original-source text checked; full methodological review pending.
Study limitations
  • No clinical benefit or regulatory approval inferred from patent grant.

Reviewed 2026-11-06.

Read the source ↗

Animal research · 2010

Morphogenetic activity of dermorphin and its analogues in different cell populations

The dissertation transcription identifies A10, A17, A43 and Sedatin as distinct synthetic analogues. Gastric and corneal DNA-synthesis responses differed across the tested peptides, arguing against a uniform tissue effect.

Study notes and original source
2010Animal / experimentalRussian-language source

Morphogenetic activity of dermorphin and its analogues in different cell populations

· Dissertation transcription

· Dissertation; primary text transcription

The dissertation transcription identifies A10, A17, A43 and Sedatin as distinct synthetic analogues. Gastric and corneal DNA-synthesis responses differed across the tested peptides, arguing against a uniform tissue effect.

Population / setting
Rat tissue experiments; dissertation transcription
Source reviewed
Selected sequence table and tissue-response conclusions checked; original scan pending.
Study limitations
  • Original scan and underlying experiment overlap still require appraisal.
  • Working codes are not marketed product identities; tissue markers do not establish human regeneration.

Reviewed 2026-10-05.

Read the source ↗

Follow shared publications or research classes. These links do not establish equivalent effects between compounds.

Research collection curated by @PepMariner · editorial standards. Send a source correction ↗

Browse bibliography & PDFs ↗